Tissue issues

Caroline Chen, a journalist at ProPublica, dives into the murky world of stem cell clinics across the U.S. She reveals how these seemingly miraculous treatments for diseases like diabetes often lack regulation and oversight. Discussing the exploitation of patients seeking hope, she highlights the deceptive marketing tactics of providers and the ethical quandaries of unapproved therapies. With a focus on the FDA's regulatory challenges, Chen stresses the urgent need for stricter safety measures and informed patient choices in this booming, yet risky industry.